G Cecchi
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
-
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 2
- Peptidase Inhibition and Analysis 1
- Cutaneous Melanoma Detection and Management 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Douglas W. Blayney (3 shared papers)Kim Margolin (2 shared papers)David A. Goldberg (1 shared paper)Lucille Leong (1 shared paper)Hector Battifora (1 shared paper)M. Margaret Kemeny (1 shared paper)Jose J. Terz (1 shared paper)David Irwin (3 shared papers)
- Journals
- Cancers (1 paper)Journal of Clinical Oncology (1 paper)Journal of Investigative Medicine (1 paper)Bone Marrow Transplantation (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
G Cecchi
8 papers receiving 177 citations
Peers
Comparison fields: 5 of 39
- Hepatology 96
- Oncology 116
- Pulmonary and Respiratory Medicine 67
- Surgery 69
- Cancer Research 20
Countries citing papers authored by G Cecchi
This map shows the geographic impact of G Cecchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Cecchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Cecchi more than expected).
Fields of papers citing papers by G Cecchi
This network shows the impact of papers produced by G Cecchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Cecchi. The network helps show where G Cecchi may publish in the future.
Co-authors
The 25 scholars most cited alongside G Cecchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 108 | |
| 2 | 1986 | 37 | |
| 3 | 2000 | 12 | |
| 4 | 2000 | 12 | |
| 5 | 2017 | 12 | |
| 6 | 1984 | 9 | |
| 7 | Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer. | 1985 | 5 |
| 8 | 2018 | 3 | |
| 9 | 2025 | 0 |
About G Cecchi
G Cecchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Dermatology, Molecular Biology and Cancer Research, having authored 9 papers that have together received 198 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Skin Protection and Aging (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hepatology (96 citations), Oncology (116 citations), Pulmonary and Respiratory Medicine (67 citations), Surgery (69 citations) and Cancer Research (20 citations). G Cecchi has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Douglas W. Blayney, Kim Margolin, David A. Goldberg, Lucille Leong, Hector Battifora, M. Margaret Kemeny, Jose J. Terz, David Irwin, Gerald E. Metter and James H. Doroshow. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Journal of Investigative Medicine, Bone Marrow Transplantation and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.